Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Note: All proteins are shipped with standard blue ice packs unless dry ice shipping is specifically requested and arranged in advance. Additional fees apply for dry ice shipping.
The tag type is determined during production. If a specific tag type is required, please inform us for preferential development.
SAR1458 is a 187-amino acid protein classified as an UPF0398 family protein in Staphylococcus aureus subsp. aureus MRSA252. The protein's structure has been computationally modeled through AlphaFold DB (AF-Q6GGW3-F1), with the model released on December 9, 2021, and last modified on September 30, 2022. The computational model demonstrates exceptionally high confidence, with a global pLDDT score of 95.77, indicating very reliable structural predictions throughout most regions of the protein . While experimental verification of this structure is currently lacking, the high confidence scores suggest the predicted fold is likely accurate. Researchers should approach structural studies by combining this computational model with experimental validation techniques such as X-ray crystallography or cryo-EM.
Experimental verification of the SAR1458 structure requires a multi-technique approach:
X-ray Crystallography: Express recombinant SAR1458 with a cleavable His-tag, purify using nickel affinity chromatography followed by size exclusion chromatography, then screen crystallization conditions. Typical buffers include 20mM Tris-HCl pH 7.5, 150mM NaCl, with various precipitants.
Circular Dichroism (CD) Spectroscopy: To confirm secondary structure elements, conduct CD scanning from 190-260nm at 20°C using purified protein at 0.1-0.5 mg/ml in phosphate buffer.
Nuclear Magnetic Resonance (NMR): For regions with lower pLDDT scores, NMR can provide residue-level dynamics information using 15N-labeled protein.
The following table outlines recommended experimental validation methods based on confidence regions in the AlphaFold model:
| pLDDT Score Range | Confidence Level | Recommended Validation Methods |
|---|---|---|
| >90 | Very high | Targeted mutation studies, limited proteolysis |
| 70-90 | Confident | CD spectroscopy, SAXS, limited proteolysis |
| 50-70 | Low | NMR dynamics studies, hydrogen-deuterium exchange |
| <50 | Very low | NMR structure determination, crystallography focus |
For recombinant expression of SAR1458, E. coli-based systems typically provide the highest yield for structural and biochemical studies. The methodological approach should include:
Vector Selection: pET-based vectors (particularly pET-28a with N-terminal His-tag) offer good expression control through T7 promoter.
Expression Strains: BL21(DE3) represents the standard choice, while Rosetta strains can accommodate rare codons if sequence analysis indicates their presence in SAR1458.
Expression Protocol:
Transform expression plasmid into chosen strain
Culture in LB or 2xYT media to OD600 of 0.6-0.8
Induce with 0.5mM IPTG
Express at 18°C overnight to minimize inclusion body formation
Harvest cells and lyse in buffer containing 50mM Tris-HCl pH 8.0, 300mM NaCl, 10mM imidazole, and protease inhibitors
For isotope labeling (for NMR studies), M9 minimal media supplemented with 15N-ammonium chloride and/or 13C-glucose should be used, with expression protocols adjusted to account for slower growth in minimal media .
When investigating SAR1458 function, researchers should implement robust experimental designs that account for both direct and indirect effects. Based on established methods for characterizing proteins of unknown function in Staphylococcus aureus:
Genetic Knockout Studies: Create SAR1458 deletion mutants using allelic replacement techniques. Implement a time-series experimental design to monitor phenotypic changes over multiple growth phases . This design allows detection of temporal effects that might be missed in single-timepoint experiments.
Complementation Analysis: After knockout studies, complement with wild-type and mutant versions of SAR1458 to confirm phenotype specificity. Use a counterbalanced design to control for position effects if integrating at different genomic loci .
Interactome Analysis: Implement pull-down experiments coupled with mass spectrometry to identify interaction partners. Use crosslinking techniques with controls for false positives through statistical validation.
Transcriptomic Response: Employ RNA-seq to analyze global transcriptional changes in SAR1458 mutants under various conditions. Design should include biological triplicates with appropriate statistical analysis for differential expression .
For all experimental designs, implement appropriate controls based on the regression-discontinuity principle to identify causal relationships rather than mere associations .
When faced with contradictory data in SAR1458 research, researchers should implement systematic approaches to identify and resolve contradictions:
Data Contradiction Analysis Framework:
Self-contradictory Data: Identify internal inconsistencies within a single experimental dataset, such as conflicting phenotypes under seemingly identical conditions .
Pair Contradictions: Recognize conflicts between two separate experiments examining the same aspect of SAR1458 .
Conditional Contradictions: Address complex scenarios where data from one experiment creates a contradiction between two other experiments when interpreted together .
Resolution Methodology:
Implement a controlled validation experiment targeting specifically the contradictory aspect
Employ orthogonal techniques to measure the same parameter
Analyze experimental conditions for subtle differences (media composition, growth phase, etc.)
Examine strain background effects, particularly in clinical versus laboratory S. aureus strains
Documentation Protocol:
Record all contradictions in a structured format
Document resolution attempts and outcomes
Report both resolved and unresolved contradictions in publications to advance field knowledge
This systematic approach prevents confirmation bias and ensures research integrity when studying a protein with limited characterized functions .
For high-quality SAR1458 purification suitable for structural studies, implement this multi-step protocol:
Initial Extraction:
Lyse cells in 50mM Tris-HCl pH 8.0, 300mM NaCl, 10mM imidazole, 1mM DTT, protease inhibitors
Use sonication (6×30s pulses) or high-pressure homogenization at 15,000 psi
Clarify lysate by centrifugation at 30,000×g for 45 minutes at 4°C
Affinity Chromatography:
Apply clarified lysate to Ni-NTA column pre-equilibrated with lysis buffer
Wash extensively with 50mM Tris-HCl pH 8.0, 300mM NaCl, 20mM imidazole
Elute with 50mM Tris-HCl pH 8.0, 300mM NaCl, 250mM imidazole gradient
Tag Removal:
Dialyze against 50mM Tris-HCl pH 8.0, 150mM NaCl, 1mM DTT
Add TEV protease at 1:50 ratio (protease:protein)
Incubate overnight at 4°C
Remove cleaved tag by reverse Ni-NTA chromatography
Polishing Step:
Apply protein to Superdex 75 column in 20mM Tris-HCl pH 7.5, 150mM NaCl, 1mM DTT
Collect fractions and analyze by SDS-PAGE
Pool fractions containing >95% pure SAR1458
Quality Assessment:
Dynamic light scattering to confirm monodispersity
Thermofluor assay to determine optimal buffer conditions
Mass spectrometry to confirm intact mass
This protocol typically yields 10-15mg of purified protein per liter of culture, sufficient for crystallization trials or NMR studies .
To determine SAR1458's physiological role, employ a multi-faceted approach combining genetics, biochemistry, and systems biology:
Conditional Expression Systems: Implement tetracycline-inducible or antisense RNA expression systems to create depletion strains when direct knockouts are lethal. Monitor growth parameters, morphology, and stress responses under varying expression levels.
Metabolic Profiling: Conduct untargeted metabolomics comparing wild-type and SAR1458 mutant strains under different growth conditions. Look specifically for:
Changes in central carbon metabolism
Alterations in nucleotide pools
Differences in amino acid biosynthesis
Cell wall precursor abundance
Transcriptional Regulation Analysis:
ChIP-seq to identify genomic binding sites if SAR1458 has DNA-binding domains
RNA-seq to identify differentially expressed genes in mutant strains
Quantitative RT-PCR validation of key targets
Localization Studies: Employ fluorescent protein fusions or immunofluorescence to determine subcellular localization, which often provides functional clues.
Phenotypic Microarrays: Test mutant and wild-type strains across hundreds of growth and stress conditions to identify specific sensitivities using Biolog plates or custom arrays .
This comprehensive approach can identify phenotypes that might be missed by single-method strategies, particularly for proteins like SAR1458 that may have condition-specific functions.
To investigate SAR1458's protein-protein interactions:
In Vivo Approaches:
Bacterial Two-Hybrid (B2H): Clone SAR1458 into both bait and prey vectors of a B2H system (e.g., BACTH). Screen against an S. aureus genomic library to identify interaction partners.
Co-Immunoprecipitation: Express epitope-tagged SAR1458 in S. aureus, crosslink in vivo, then immunoprecipitate and identify binding partners via mass spectrometry.
Proximity-Dependent Biotin Identification (BioID): Fuse SAR1458 to a biotin ligase, express in S. aureus, and identify proximal proteins through streptavidin pulldown and mass spectrometry.
In Vitro Approaches:
Pull-Down Assays: Use purified His-tagged SAR1458 as bait with S. aureus lysate, then identify bound proteins by mass spectrometry.
Surface Plasmon Resonance (SPR): Immobilize purified SAR1458 on a sensor chip and measure binding kinetics with candidate partner proteins.
Isothermal Titration Calorimetry (ITC): Measure binding thermodynamics between SAR1458 and putative interaction partners.
Computational Predictions:
Use structure-based docking to predict interactions with other S. aureus proteins
Employ co-evolution analysis to identify potentially interacting proteins
Analyze genomic context for gene neighborhood conservation
Validation Studies:
Mutagenesis of key residues to disrupt predicted interactions
Functional assays to determine biological significance of interactions
Co-crystal structure determination of protein complexes
These approaches should be used in combination, as each has specific strengths and limitations for detecting different types of protein interactions .
To comprehensively characterize post-translational modifications (PTMs) of SAR1458:
Mass Spectrometry-Based Approaches:
Bottom-Up Proteomics: Digest purified SAR1458 with trypsin and analyze peptides by LC-MS/MS. Use neutral loss scanning for phosphorylation and precursor ion scanning for glycosylation.
Top-Down Proteomics: Analyze intact SAR1458 by high-resolution MS to determine exact masses of all proteoforms.
Targeted MS: Develop multiple reaction monitoring (MRM) assays for predicted modification sites based on motif analysis.
Modification-Specific Enrichment:
Phosphorylation: Enrich phosphopeptides using TiO2 or immobilized metal affinity chromatography (IMAC)
Glycosylation: Use lectin affinity chromatography for glycopeptide enrichment
Acetylation: Immunoprecipitate with anti-acetyllysine antibodies
Site-Specific Mutagenesis:
Mutate predicted modification sites to non-modifiable residues
Compare wild-type and mutant protein function in vivo
Assess impact on protein stability, localization, and interaction profile
In Vitro Modification Assays:
Incubate purified SAR1458 with S. aureus kinases/acetyltransferases
Monitor modification by mobility shift or specific antibodies
Identify modifying enzymes through activity-based protein profiling
Researchers should be particularly attentive to condition-dependent modifications, as S. aureus proteins often show different modification patterns under stress conditions versus normal growth .
The high-confidence AlphaFold structure of SAR1458 (global pLDDT score of 95.77) provides an excellent starting point for structure-based drug discovery. Researchers should follow this methodological framework:
Druggable Pocket Identification:
Use computational tools such as SiteMap, FTMap, or CryptoSite to identify potential binding pockets
Calculate pocket volumes, hydrophobicity, and evolutionary conservation
Prioritize pockets with high conservation and suitable physicochemical properties
Virtual Screening Workflow:
Prepare a diverse compound library (consider ZINC, ChEMBL, or proprietary libraries)
Implement hierarchical screening: pharmacophore filtering → docking → molecular dynamics
Score compounds using consensus scoring with multiple force fields
Experimental Validation Pipeline:
Thermal shift assays (TSA) to confirm direct binding
Surface plasmon resonance (SPR) or isothermal titration calorimetry (ITC) for binding kinetics
Co-crystallization attempts with top hits to validate binding mode
Optimization Strategy:
Structure-activity relationship studies based on validated hits
Fragment-based approaches for low-affinity but high-efficiency binders
Consider allosteric sites in addition to orthosteric pockets
When working with computational models rather than experimental structures, researchers should apply more stringent filters to account for potential inaccuracies, focusing primarily on regions with pLDDT scores above 90 .
To investigate SAR1458's potential role in pathogenesis:
Infection Models:
In Vitro: Compare wild-type and SAR1458 mutant strains in:
Macrophage survival assays
Neutrophil killing assays
Epithelial cell adhesion and invasion models
In Vivo: Implement appropriate animal models based on infection site:
Skin infection model (subcutaneous infection)
Systemic infection model (tail vein injection)
Device-associated infection model (implanted catheters)
Virulence Factor Expression Analysis:
Quantify major virulence factor expression via qRT-PCR
Measure toxin production through ELISA or functional hemolysis assays
Monitor global virulence regulator activity (Agr, SarA, etc.)
Host-Pathogen Interaction Studies:
Assess host immune response to wild-type versus mutant strains
Measure cytokine/chemokine production by infected host cells
Analyze neutrophil extracellular trap (NET) formation and bacterial survival
Comparative Analysis Under Infection-Relevant Conditions:
SAR1458 expression during different infection stages
Behavior under host-mimicking conditions (low pH, oxidative stress, nutrient limitation)
Response to antibiotic treatment in wild-type versus mutant strains
These approaches should be conducted with appropriate controls and statistical analysis, using the equivalent time-samples design or multiple time-series design for tracking infection progression .
If SAR1458 proves essential for S. aureus viability, implement these conditional knockout strategies:
Inducible Expression Systems:
Tetracycline-Regulated System:
Replace native promoter with tetO operator sequences
Express TetR repressor from a constitutive promoter
Add anhydrotetracycline (ATc) to repress SAR1458 expression
Monitor phenotypes at varying levels of depletion
IPTG-Inducible System:
Replace native promoter with Pspac
Express LacI repressor on the same construct
Titrate IPTG concentration to control expression levels
Degron-Based Systems:
Fuse SAR1458 to SsrA degradation tag variants
Express modified SspB adaptor protein under inducible control
Induce degradation through adaptor protein expression
CRISPRi Approach:
Express dCas9 under inducible promoter
Design multiple sgRNAs targeting SAR1458 coding sequence
Induce dCas9 to block transcription without genome editing
Analysis Protocol:
Confirm depletion via Western blot and RT-qPCR
Monitor growth rate, morphology, and viability during depletion
Perform transcriptomics and metabolomics at defined depletion timepoints
Use time-series design to capture transition phenotypes before lethality
Each system has advantages and limitations; the optimal choice depends on experimental goals and resources. For non-lethal but severe phenotypes, the equivalent time-samples design allows for repeated measurements under controlled depletion conditions .
For robust statistical analysis of SAR1458 functional data:
Experimental Design Considerations:
Implement factorial designs to assess multiple factors simultaneously
Use nested classifications when analyzing hierarchical data (e.g., multiple strains, conditions)
Apply time-series experimental design for temporal phenotypes
Consider counterbalanced designs to control for order effects in sequential experiments
Statistical Methods by Data Type:
Growth/Phenotypic Data:
ANOVA with appropriate post-hoc tests for parametric data
Kruskal-Wallis for non-parametric distributions
Mixed-effects models for repeated measures
Omics Data:
Differential expression analysis with multiple testing correction
Enrichment analysis for functional categorization
Network-based approaches for identifying affected pathways
Structural Data:
Bootstrap analysis for assessing model confidence
Geometric statistics for conformational analysis
Cluster analysis for identifying conformational states
Addressing Specific Challenges:
Validation Approaches:
Cross-validation for predictive models
Independent biological replicates (not just technical replicates)
Orthogonal techniques to confirm key findings
When reporting results, provide complete statistical details including test selection rationale, exact p-values, and effect sizes, not just significance indicators .
When faced with contradictory data about SAR1458 function:
Systematic Contradiction Analysis Framework:
Technical Investigation:
Examine methodological differences (buffers, tags, expression systems)
Assess protein quality and integrity across experiments
Evaluate instrument calibration and data processing pipelines
Biological Investigation:
Consider strain background effects (laboratory vs. clinical isolates)
Evaluate growth conditions and stress responses
Assess potential context-dependent functions
Statistical Reassessment:
Re-evaluate significance thresholds and multiple testing corrections
Implement more robust statistical methods where appropriate
Consider Bayesian approaches to incorporate prior knowledge
Resolution Documentation:
Create a detailed record of contradiction investigation
Document hypotheses tested and outcomes
Present both resolved and unresolved contradictions transparently in publications
This systematic approach prevents selective reporting bias and enhances research reproducibility while advancing understanding of context-dependent protein functions .
To predict SAR1458 function through bioinformatics:
Sequence-Based Analysis:
Homology Search: BLAST, HHpred, and HMMER against curated databases
Motif Analysis: PROSITE, MEME, and ScanProsite for functional motifs
Domain Identification: InterProScan, CDD, and SMART
Genomic Context: STRING database for conserved gene neighborhoods
Structure-Based Approaches:
Structural Alignment: DALI, TM-align, and FATCAT against PDB database
Binding Site Prediction: SiteEngine, COFACTOR, and FTSite
Electrostatic Analysis: APBS for surface charge distribution
Molecular Dynamics: GROMACS or NAMD simulations to identify flexible regions
Integrated Prediction Pipelines:
COFACTOR/COACH: Integrates sequence and structure for function prediction
I-TASSER suite: Combines multiple approaches for comprehensive annotation
ConSurf: Evolutionary conservation mapping onto structure
Analysis Workflow:
Begin with basic sequence analysis (BLAST, domain prediction)
Progress to structure-based comparisons using the AlphaFold model
Apply specialized tools based on initial findings
Integrate results through scoring matrices for confident predictions
Validate top predictions experimentally
For the SAR1458 protein with its high-quality AlphaFold structure (pLDDT 95.77), structure-based methods may provide more specific functional insights than sequence-based approaches alone .
Based on current knowledge and methodological approaches, the most promising research directions for SAR1458 include:
Comprehensive Functional Characterization:
Integration of transcriptomics, proteomics, and metabolomics data from SAR1458 mutants
Condition-specific phenotyping under various stress conditions
Investigation of potential regulatory roles in S. aureus physiology
Structural Biology Advances:
Experimental validation of the AlphaFold structure through X-ray crystallography
Structure determination of SAR1458 in complex with interaction partners
Dynamic structural studies using NMR or hydrogen-deuterium exchange mass spectrometry
Translational Applications:
Assessment of SAR1458 as a potential drug target or biomarker
Development of inhibitors targeting SAR1458 function
Evaluation of conservation across clinical S. aureus isolates
Methodological Innovations:
Application of cryo-electron tomography for in situ visualization
Development of SAR1458-specific biosensors to monitor activity
Implementation of machine learning approaches to predict function from structure
Integration with Systems Biology:
Placement of SAR1458 within S. aureus regulatory networks
Modeling of SAR1458's contribution to bacterial homeostasis
Comparative analysis across different staphylococcal species
These directions should be pursued using robust experimental designs and appropriate statistical approaches to ensure reproducible and meaningful advances in understanding this protein's role in S. aureus biology .
To address knowledge gaps about SAR1458 function:
Strategic Experimental Planning:
Targeted Approaches for Specific Knowledge Gaps:
Biochemical Function: Combine structural predictions with targeted assays (e.g., testing predicted enzymatic activities)
Interaction Network: Implement systematic interactome mapping using complementary techniques
Regulatory Role: Combine ChIP-seq, RNA-seq, and promoter analysis if DNA-binding is predicted
Stress Response: Test mutant phenotypes under clinically relevant stress conditions
Multi-Scale Investigation:
Single-cell level: Fluorescence microscopy for localization and dynamics
Population level: Growth and competition assays
Systems level: Multi-omics integration and network analysis
Host-pathogen interface: Infection models and immune response
Validation Framework:
Independent validation of key findings through orthogonal methods
Genetic complementation with wild-type and mutant variants
Cross-species comparison with orthologs from related staphylococci
By implementing these systematic approaches with appropriate controls and statistical analyses, researchers can efficiently address knowledge gaps while minimizing experimental bias and maximizing reproducibility .
Emerging methodological innovations with high potential to accelerate SAR1458 research include:
Advanced Structural Biology Techniques:
Cryo-Electron Tomography: For visualizing SAR1458 in its native cellular context
Integrative Structural Biology: Combining multiple experimental data types with computational modeling
Time-Resolved Structural Methods: Capturing structural dynamics during function
Genome Engineering Advances:
CRISPR Interference (CRISPRi): For tunable gene repression without genome editing
Base Editing: For precise nucleotide substitutions without double-strand breaks
Multiplex Genome Engineering: For simultaneous modification of SAR1458 and potential partners
Single-Cell Technologies:
Single-Cell RNA-Seq: For heterogeneity analysis in SAR1458 mutant populations
Single-Cell Proteomics: For protein-level phenotyping
Microfluidics-Based Approaches: For high-throughput phenotypic screening
Artificial Intelligence Applications:
Deep Learning for Function Prediction: Beyond traditional bioinformatics approaches
Machine Learning for Experimental Design: To optimize conditions and reduce experimental iterations
AI-Augmented Data Analysis: For identifying subtle phenotypes and complex relationships
Advanced Imaging Innovations:
Super-Resolution Microscopy: For detailed subcellular localization
Correlative Light and Electron Microscopy (CLEM): For connecting function to ultrastructure
Spatial Transcriptomics/Proteomics: For location-specific functional analysis